Skip to main content

COVID-19: Lessons from the ‘Spanish lifestyle’ terminator

COVID-19 has hit Spain particularly hard. The first wave of the virus, suffered in late winter and spring 2020, was one of the worst in the European Union (EU), requiring a strict stay-at-home lockdown of over 100 days between 15 March and 21 June. Banning mobility affected the Spanish economy since it is one of the most open countries in the world, receiving, on average, over 80 million visitors every year. Tourism accounts for 12 percent of GDP and 13 percent of employment. This structural factor partly explains the steep decline of 18.5 percent of GDP in the second quarter of 2020, way above the EU GDP, which contracted by “only” 11.7 percent.

The situation remains dire. Annual GDP contraction  for 2020 will be around 12 percent, the deepest since the Civil War in the 1930s. The fiscal deficit will be north of 10 percent, and unemployment will be close to 20 percent. More worrying, the health situation is worsening, with the threat of a second wave at the end of the summer and beginning of autumn looming. At the end of August, with over 3,000 new cases every day, Spain has the highest incidence of COVID-19 in Western Europe. Spain’s numbers are currently three times higher than those of Italy, which had a similar trajectory during the first wave. Spanish experts and researchers are still trying to explain why Spain is such an outlier in Europe and why there is such a difference with Italy, a similar country geographically and culturally.

There are multiple possible factors. Perhaps Spain is testing more than Italy, but it can also be that the Spanish lifestyle,  especially during the summer, is more prone to contagion. Furthermore, quickly opening all businesses in June for the summer season to attract tourists was a national urgency. In hindsight, it might have been a mistake to open bars, clubs and discotheques until late hours. Italy has not allowed that and has maintained its state of emergency to impose targeted lockdowns. It appears that Italy has better tracing capacities than Spain, which still has relatively low ratios of trackers per 1000 people in most of its autonomous regions.

Number of cases and deaths


According to the information reported by individual countries,  Spain, the 30th largest country in the world in terms of population, currently ranks ninth in terms of absolute number of cases, as of 4 September. While it is imperative to view these statistics with consummate care, both because of the scant transparency shown by some countries and because of the objective counting difficulties associated with an illness where a considerable proportion of infected patients are asymptomatic, there can be little doubt that Spain is at the forefront of COVID-19 incidence, at least in Europe, and this is also confirmed by the first studies into seroprevalence  (level of a pathogen in a population measured in blood serum) where, in theory, problems of undercounting are avoided.

The questions and lack of homogeneity regarding official information also arise when one turns to the number of deaths, a statistic that has understandably been viewed as more important for determining the real impact of the disease. According to the official figures at the time of writing,  Spain ranks eighth in the world in terms of the absolute number of deaths (below seven more populous countries — the US, Brazil, Mexico, India, UK, Italy and France). When the ranking is carried out relative to population size, and once micro-countries have been removed, Spain is ranked only behind Belgium and Peru in mortality, with similar numbers to those of the UK.


Comments

Popular posts from this blog

Iran, Russia Discussing Joint Production Of COVID-19 Vaccine

Iran and Russia's sovereign wealth fund RDIF are discussing the joint production of a vaccine against COVID-19, Russian news agencies cited the Iranian ambassador to Moscow as saying on Friday. "We are holding talks, I spoke with the head of RDIF Kirill Dmitriev, our officials have held several rounds of consultations and we announced that we will co-operate," Ambassador to Moscow Kazem Jalali was cited as saying. Thus far, Russia has struck a manufacturing partnership deal with India, which is due to produce 300 million doses of the 'Sputnik-V' vaccine domestically. It is also discussing such partnerships with several other countries, including Brazil.

Increased risks of drop out for women and girls : CoronaVirus Updates

The total number of children not returning to their education after the school closures is likely to be significant. The pandemic also risks jeopardizing some of the gains made since 2001 in re-building women and girls’ education following the Taliban regime.  The COVID-19 pandemic is creating additional barriers due to risks—and students’ and parents’ anxiety about risks—associated with children returning to classrooms that are cramped, with no capacity for distancing, often cold, damp and poorly ventilated during the country’s severe winters, and have no or poor hygiene and clean water facilities. The COVID-19 pandemic is likely to drive many women and girls out of education permanently. School closures due to COVID-19, resulting increases in caregiving responsibilities for women and girls, and increases in poverty and unemployment will all make it harder for women and girls to study.  These factors combine in harmful ways with pre-existing discriminatory gender norms, o...

Russia's Covid-19 vaccine Sputnik V available to public now: State media

First batches of Russia's Covid vaccine Sputnik V have entered "civil circulation" in capital Moscow, state media reported on Thursday. While details on the process were not immediately available, Russia has repeatedly stressed on producing the vaccine at the earliest, a belief met with international scepticism. Earlier this month, the Russian health ministry had said that batches of the Covid-19 vaccine were being produced for public distribution and would be supplied to different regions soon. "The first batch of the vaccine for preventing the novel coronavirus infection, Gam-COVID-Vac (Sputnik V) developed by the Gamaleya Research Institute of Epidemiology and Microbiology of the Russian Health Ministry passed the required quality tests in the laboratories of Roszdravnadzor (the Federal Service for Surveillance in Healthcare) and was produced for civilian circulation. In the near future the supplies of the first batches of the vaccine to the regions are expected...